Telix Pharmaceuticals (TLPPF) Short Interest Ratio & Short Volume $14.00 -0.40 (-2.78%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Telix Pharmaceuticals Short Interest DataTelix Pharmaceuticals (TLPPF) has a short interest of 1.01 million shares. This marks a -15.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 186.7, indicating that it would take 186.7 days of the average trading volume of 7,021 shares to cover all short positions.Current Short Interest1,008,100 sharesPrevious Short Interest1,193,100 sharesChange Vs. Previous Month-15.51%Dollar Volume Sold Short$13.45 millionShort Interest Ratio186.7 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume12,183 sharesAverage Trading Volume7,021 sharesToday's Volume Vs. Average174% Short Selling Telix Pharmaceuticals? Sign up to receive the latest short interest report for Telix Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTLPPF Short Interest Over TimeTLPPF Days to Cover Over TimeTLPPF Percentage of Float Shorted Over Time Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Telix Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,008,100 shares $13.45 million -15.5%N/A186.7 $13.34 10/15/20241,193,100 shares $17.27 million -4.8%N/A213.1 $14.48 9/30/20241,253,600 shares $18.40 million -3.2%N/A101.9 $14.68 9/15/20241,295,000 shares $16.51 million -3.5%N/A168.2 $12.75 8/31/20241,341,500 shares $18.11 million +47.1%N/A145.8 $13.50 8/15/2024912,200 shares $11.27 million +17.4%N/A86.1 $12.35 Get the Latest News and Ratings for TLPPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024777,300 shares $9.56 million -64.0%N/A30 $12.30 7/15/20242,156,100 shares $29.54 million +2.7%N/A79.3 $13.70 6/30/20242,100,100 shares $26.57 million -6.1%N/A50.1 $12.65 6/15/20242,235,900 shares $24.39 million +59.8%N/A96 $10.91 5/31/20241,399,600 shares $17.10 million -0.2%N/A91.5 $12.22 5/15/20241,401,700 shares $14.31 million -6.6%N/A152.4 $10.21 4/30/20241,501,300 shares $14.71 million +12.8%N/A114.6 $9.80 4/15/20241,330,700 shares $11.55 million +4.8%N/A187.4 $8.68 3/31/20241,270,300 shares $10.73 million -5.4%N/A105.9 $8.45 3/15/20241,343,200 shares $10.38 million -1.3%N/A319.8 $7.73 2/29/20241,360,300 shares $11.20 million +2.9%N/A42.6 $8.23 2/15/20241,321,400 shares $10.03 million -27.0%N/A236 $7.59 1/15/20242,000,500 shares $14.00 million -1.5%N/A384.7 $7.00 12/31/20232,031,100 shares $13.96 million +4.6%N/A209.2 $6.88 12/15/20231,942,400 shares $12.59 million +3.5%N/A194.2 $6.48 11/30/20231,876,000 shares $12.25 million +35.2%N/A1103.5 $6.53 11/15/20231,387,200 shares $8.66 million +119.4%N/A182.5 $6.24 10/31/2023632,300 shares $3.60 million +16.6%N/A71 $5.70 10/15/2023542,100 shares $3.85 million -2.5%N/A115.3 $7.11 9/30/2023555,700 shares $4.11 million +2.4%N/A104.8 $7.39 9/15/2023542,800 shares $3.99 million +1.4%N/A113.1 $7.35 8/31/2023535,300 shares $3.88 million +57.3%N/A94.7 $7.26 8/15/2023340,400 shares $2.29 million +203.4%N/A68.1 $6.74 7/31/2023112,200 shares $835,890.00 -20.3%N/A15.6 $7.45 7/15/2023140,800 shares $0.00 +3.2%N/A27.1 $0.00 TLPPF Short Interest - Frequently Asked Questions What is Telix Pharmaceuticals' current short interest? Short interest is the volume of Telix Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,008,100 shares of TLPPF short. Learn More on Telix Pharmaceuticals' current short interest. What is a good short interest ratio for Telix Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLPPF shares currently have a short interest ratio of 187.0. Learn More on Telix Pharmaceuticals's short interest ratio. Is Telix Pharmaceuticals' short interest increasing or decreasing? Telix Pharmaceuticals saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 1,008,100 shares, a decline of 15.5% from the previous total of 1,193,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Telix Pharmaceuticals stock? Short selling TLPPF is an investing strategy that aims to generate trading profit from Telix Pharmaceuticals as its price is falling. TLPPF shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Telix Pharmaceuticals? A short squeeze for Telix Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TLPPF, which in turn drives the price of the stock up even further. How often is Telix Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLPPF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Interest TRSBF Short Interest AGNPF Short Interest DRTSW Short Interest WENAW Short Interest APLMW Short Interest ASPHF Short Interest ASCLF Short Interest AVCTF Short Interest AWKNF Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:TLPPF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.